Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to allegations of misleading investors regarding its integration with 3M Company, which has negatively impacted its financial health [2][3]. Financial Performance - On January 10, 2025, Neogen reported a GAAP net income that was significantly negative, primarily due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition [3]. - Neogen cut its fiscal year 2025 revenue and EBITDA guidance following the negative financial disclosures [3]. - On April 9, 2025, Neogen announced a quarterly revenue decline of 3.4% to $221 million, attributing part of this to integration issues, and again revised its FY25 revenue and EBITDA outlook downward [4]. - The company projected capital expenditures of $100 million due to lowered adjusted EBITDA and a pull-forward of integration-related capital expenditures into FY25 [4]. - On June 4, 2025, Neogen expected its EBITDA margin to be in the high teens, a significant drop from the previous quarter's margin of 22% [5]. Stock Performance - Following the January 10, 2025 announcement, Neogen's stock price fell by 5% to close at $12.36 per share [3]. - After the April 9, 2025 announcement, the stock price plummeted by 28% [4]. - By June 4, 2025, the stock price had further declined by 17%, closing at $4.96 per share, marking a total drop of $18.88 per share or 79% from its August 15, 2023 high of $23.84 per share, erasing over $4 billion in market capitalization [5].

On July 18, 2025, an investor in shares of Neogen Corporation (NASDAQ: NEOG) filed a lawsuit against Neogen Corporation over alleged violations of securities laws. The plaintiff alleged that the defendants misrepresented the status of the 3M integration and failed to disclose the negative impact of integration issues on the financial health of Neogen, that the defendants issued a series of materially false and misleading statements which led investors to believe that the integration was progressing smoothly ...

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ("Neogen Corporation" or the "Company") (NASDAQ: NEOG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Neogen Corporation investors who were adversely affected by alleged securities fraud between January 5, 2023 and June 3, 2025. Follow the link below to get more information and be contacted by a member of our team: WHAT'S NEXT? If you suffered a los ...

Core Viewpoint - Neogen Corporation is facing a class action securities lawsuit due to alleged securities fraud that misled investors regarding the integration with 3M Company's Food Safety Division [1][2] Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by misleading statements made between January 5, 2023, and June 3, 2025 [1] - Defendants allegedly issued false statements about the progress of the integration, leading investors to have an inflated perception of its success [2] - When inefficiencies from the integration were revealed, the defendants downplayed these issues and reassured investors of their commitment to resolving them [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 16, 2025, to request appointment as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3] Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and being recognized as a top securities litigation firm in the U.S. for seven consecutive years [4]

https://securitiesclasslaw.com/securities/neogen-corporation-loss-submission-form/?id=160431&from=4 CLASS PERIOD: January 5, 2023 to June 3, 2025 ALLEGATIONS: According to the filed complaint, defendants issued a series of materially false and misleading statements which led investors to believe that the integration with the Food Safety Division of the 3M Company was progressing much better than it actually was. In addition, even when the Company was forced to reveal that certain "inefficiencies" arose as a ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Neogen Corporation common stock between January 5, 2023, and June 3, 2025, of the September 16, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Neogen common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5] - The lead plaintiff must file a motion with the court by September 16, 2025, to represent other class members [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3] Group 3: Case Allegations - The lawsuit alleges that Neogen's defendants made false and misleading statements about the integration process, claiming it was progressing smoothly when it was not [4] - Initially, defendants stated that the integration was "off to a great start" and that Neogen was experiencing solid core growth and profitability [4] - Despite acknowledging certain "inefficiencies" during the integration, defendants downplayed these issues, leading to investor damages when the true situation was revealed [4]

Core Viewpoint - Neogen Corporation is facing a class action securities lawsuit due to alleged securities fraud that misled investors regarding the integration with 3M Company's Food Safety Division [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by misleading statements made between January 5, 2023, and June 3, 2025 [1]. - Defendants allegedly issued false statements about the integration's progress and downplayed inefficiencies that arose during the process [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 16, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and being recognized as a top securities litigation firm in the U.S. for seven consecutive years [4].

Core Viewpoint - Neogen Corporation is facing a class action securities lawsuit due to alleged securities fraud that misled investors regarding the integration with the Food Safety Division of 3M Company [1][2] Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by misleading statements made between January 5, 2023, and June 3, 2025 [1] - Defendants allegedly issued materially false statements about the integration's progress and downplayed inefficiencies that arose during the process [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 16, 2025, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and ranked among the top securities litigation firms in the U.S. for seven consecutive years [4]

Core Viewpoint - Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [3]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [3]. - The complaint alleges that Neogen's management downplayed inefficiencies arising from the integration and misled investors about their commitment to resolving these issues [3]. - Shareholders are encouraged to register for the class action by September 16, 2025, to potentially be appointed as lead plaintiffs [4]. Group 2: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged misleading statements and failure to disclose material facts regarding the integration of 3M's Food Safety Division, leading to significant financial losses for investors [4][7]. Group 1: Company Overview - Neogen Corporation develops, manufactures, and markets products focused on food and animal safety, and completed a strategic merger with 3M's Food Safety Division in September 2022 [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Neogen misrepresented the progress of the integration, which was actually facing operational and financial difficulties [5]. - Neogen reported a GAAP net loss of $461 million due to a non-cash goodwill impairment related to the 3M acquisition, along with downward revisions to revenue and EBITDA guidance for 2025 [5]. - In Q3 2025, Neogen experienced a net loss of $11 million, a decline in revenue by 3.4% to $221 million, and increased capital expenditures projected at $100 million due to integration spending [5]. - Following these disclosures, Neogen's stock fell approximately 28% and then dropped more than 17% after announcing a significant decline in EBITDA margin expectations [6].